Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Granulocyte colony-stimulating factor production and rapid progression of gastric cancer after histological change in the tumor.

Yamano T, Morii E, Ikeda J, Aozasa K.

Jpn J Clin Oncol. 2007 Oct;37(10):793-6. Epub 2007 Aug 24.

PMID:
17720735
3.

BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.

Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML, Lacout C, Guilhot F, Vainchenker W, Turhan AG.

Br J Haematol. 2006 Jul;134(2):171-9.

PMID:
16846476
4.
5.

Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions.

Yin W, Cheepala S, Roberts JN, Syson-Chan K, DiGiovanni J, Clifford JL.

Mol Cancer. 2006 Apr 7;5:15.

6.

Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.

Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J, Jove R.

Mol Cancer Ther. 2006 Mar;5(3):621-9.

7.

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.

Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.

Clin Cancer Res. 2006 Jan 1;12(1):11-9.

8.

Promoting apoptosis as a strategy for cancer drug discovery.

Fesik SW.

Nat Rev Cancer. 2005 Nov;5(11):876-85. Review. Erratum in: Nat Rev Cancer. 2005 Dec;5(12):995.

PMID:
16239906
10.

Paraneoplastic syndromes in cancer: Case 2. Leucocytosis associated with liposarcoma recurrence: original presentation of liposarcoma recurrence.

des Guetz G, Mariani P, Freneaux P, Pouillart P.

J Clin Oncol. 2004 Jun 1;22(11):2242-3. No abstract available.

PMID:
15169814
11.

Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma.

Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K.

Cancer. 2001 Nov 1;92(9):2399-405.

PMID:
11745296
12.

Malignant fibrous histiocytoma of soft tissue producing granulocyte colony-stimulating factor.

Mayumi E, Okuno T, Ogawa T, Kurata K, Ishioka H, Hamamoto H, Ishiki K, Maga T, Okamoto T, Yoshida T, Ogura Y.

Intern Med. 2001 Jun;40(6):536-40.

13.

A leukemoid reaction in a patient with a dedifferentiated liposarcoma.

Nasser SM, Choudry UH, Nielsen GP, Ott MJ.

Surgery. 2001 Jun;129(6):765-7. No abstract available.

PMID:
11391379
14.

Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors.

Hirai K, Kumakiri M, Fujieda S, Sunaga H, Lao LM, Imamura Y, Ueda K, Fukuda M.

J Dermatol Sci. 2001 Apr;25(3):179-88.

PMID:
11240265
15.

Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas.

Savarese TM, Mitchell K, McQuain C, Campbell CL, Guardiani R, Wuu J, Ollari C, Reale F, Nelson BE, Chen A, Quesenberry PJ.

Cancer Lett. 2001 Jan 10;162(1):105-15.

PMID:
11121868
17.
18.
19.

A mesenteric liposarcoma with production of granulocyte colony-stimulating factor.

Nakamura A, Tanaka S, Takayama H, Sakamoto M, Ishii H, Kusano M, Onizuka Y, Ota S, Mitamura K.

Intern Med. 1998 Oct;37(10):884-90. Review.

20.

IL-6 in a pleomorphic type of malignant fibrous histiocytoma presenting high fever.

Hamada T, Komiya S, Hiraoka K, Zenmyo M, Morimatsu M, Inoue A.

Hum Pathol. 1998 Jul;29(7):758-61.

PMID:
9670836

Supplemental Content

Support Center